Variables observed included the use of HBOT and normobaric conditions in people with diabetes mellitus (mainly those with type 2 diabetics mellitus) with assessment of changes in insulin levels, insulin sensitivity, OGTT, and HbA1c (Table 4). The gene discussed is INS; the disease is diabetes mellitus.